Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
about
Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasitesVar2CSA minimal CSA binding region is located within the N-terminal regionEvasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malariaInduction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites.The density of knobs on Plasmodium falciparum-infected erythrocytes depends on developmental age and varies among isolates.High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria.Designing a VAR2CSA-based vaccine to prevent placental malaria.Mother-to-Children Plasmodium falciparum Asymptomatic Malaria Transmission at Saint Camille Medical Centre in Ouagadougou, Burkina Faso.Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1.VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placentaThe antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding siteMalaria and immunity during pregnancy and postpartum: a tale of two speciesHigh levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 Variants per Genome Can Bind IgM via Its Fc Fragment FcμComparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.Influence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian WomenAntibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.B-cell responses to pregnancy-restricted and -unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites.Pre-clinical and clinical development of the first placental malaria vaccine.The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria.VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.[Effect of intermittent presumptive treatment with sulfadoxine-pyrimethamine on the acquisition of anti-VAR2CSA antibodies in pregnant women living in a hypoendemic area in Senegal].Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.Natural and Vaccine-Induced Acquisition of Cross-Reactive IgG-Inhibiting ICAM-1-Specific Binding of a Plasmodium falciparum PfEMP1 Subtype Associated Specifically with Cerebral Malaria.Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes.
P2860
Q28540204-9E8BB095-3ED5-4FE3-A337-9F2C20EBAA94Q28744428-1B60D16B-A108-4D18-AD1B-CBB80994A9BEQ30502964-7F8CD7CB-9CC1-41D6-81E3-71248ED18737Q30603697-2AD04D14-AAAA-404E-8A1D-7CF2D0753E79Q34244920-8A7EC53C-A9B2-4756-B9E1-C2AAB31689EBQ34303336-C72626E7-48D2-4919-BF0D-E2646DA057FCQ34326742-B2FF5623-FDDE-4826-831A-1D5DDF3DE95BQ34498103-762EA7F1-9218-4A17-9FC5-04C94CFC1BA6Q34651686-0D830667-B417-4B4C-93ED-B420DFC8E967Q34660001-01C6023A-4B24-4232-B9B0-76A71DF09450Q34853037-F8724A76-776A-46D6-864F-55B0DB066D76Q34921119-AC1FE7E7-7185-40A4-B717-A4C8BDE88798Q35088554-0DE8F9D9-065F-4A02-BCBC-779B45C958FBQ35678578-B8E3B90E-A55B-4923-BB6F-E5FF3471E787Q35867607-2DBA26E6-A7A3-446C-AA10-63BD0A980F68Q36053493-DA0CA42B-E8EE-4B4B-9373-9339A1CFE7DBQ36336978-7697F53D-D8F3-4A36-A55F-D4479351948FQ36644516-A196090B-1E99-4A47-8CAA-DB5C423D2807Q37396439-1E260858-3D0A-4102-B305-C83C0DF5FF91Q37499204-B94C916F-731C-4C2B-91B9-B505C70DA71BQ37713335-C5D10082-35F4-4132-9079-366CC4E6174CQ38691920-B2F4F51F-1F2A-4C95-822D-F751FA9E097DQ39698908-135EA042-18CC-4C4C-B684-E90576B4A3A7Q40670564-8C943578-58AF-482B-817A-4C0B81998E14Q46543432-2ED4DB33-A2B5-461E-A092-171AD92B1F77Q48023771-6B9971E4-EE31-44B5-AEB5-688407D9FA8DQ50095537-56F40AD9-F0C8-4440-8E3D-C362F13A6D8BQ54258919-9C7226B4-A107-40B4-8207-3E9638087DEE
P2860
Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Chondroitin sulfate A-adhering ...... s shared by multiple variants.
@ast
Chondroitin sulfate A-adhering ...... s shared by multiple variants.
@en
type
label
Chondroitin sulfate A-adhering ...... s shared by multiple variants.
@ast
Chondroitin sulfate A-adhering ...... s shared by multiple variants.
@en
prefLabel
Chondroitin sulfate A-adhering ...... s shared by multiple variants.
@ast
Chondroitin sulfate A-adhering ...... s shared by multiple variants.
@en
P2093
P2860
P50
P356
P1476
Chondroitin sulfate A-adhering ...... s shared by multiple variants.
@en
P2093
Davis John
Firmine Viwami
Jonas Bruun
Madeleine Dahlbäck
Michal Fried
Nadia L Bernasconi
Pamela Magistrado
Pongsak Khunrae
Tina Dobrilovic
P2860
P304
P356
10.4049/JIMMUNOL.1002390
P407
P50
P577
2010-11-15T00:00:00Z